Adaptive Biotech (ADPT) Q4 Loss of $13.6M Exceeds Estimates

Adaptive Biotechnologies Corp. (ADPT) released Q4 results showing a loss of $13.6 million, or 9 cents per share, outperforming the Zacks average estimate of 19 cents per share. Revenue for the quarter totaled $71.7 million. For the year, the company reported a loss of $59.5 million, or 39 cents per share, with revenue reaching $277 million. ADPT shares rose to $16.46 at the close of trading on February 5, 2026, reflecting a more than doubling over the past 12 months.